黑色素瘤的新型筛查方法
New Screening Methods in Melanoma.
作者信息
Czerw Aleksandra, Deptała Andrzej, Partyka Olga, Pajewska Monika, Badowska-Kozakiewicz Anna, Budzik Michał, Sygit Katarzyna, Kopczyński Zygmunt, Czarnywojtek Piotr, Cipora Elżbieta, Konieczny Magdalena, Banaś Tomasz, Grochans Elżbieta, Grochans Szymon, Cybulska Anna Maria, Schneider-Matyka Daria, Bandurska Ewa, Ciećko Weronika, Drobnik Jarosław, Pobrotyn Piotr, Grata-Borkowska Urszula, Furtak-Pobrotyn Joanna, Sierocka Aleksandra, Marczak Michał, Kozlowski Remigiusz
机构信息
Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.
Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
出版信息
Cancers (Basel). 2024 Dec 16;16(24):4186. doi: 10.3390/cancers16244186.
BACKGROUND
The World Health Organisation reports that melanoma had an incidence of 331,722 cases worldwide in 2022, ranking it 17th on the list of the most prevalent malignancies. This disease is a threat to public health as years of potential life lost from melanoma deaths constitute an economic and social burden; it is, however, curable if detected early. This study aims to show current trends in clinical trials for melanoma screening.
MATERIALS AND METHODS
The analysis was conducted using data from clinicaltrials.gov. The analysis considered both interventional and observational studies on melanoma screening. Only the studies with complete and active statutes by 4 September 2024 were included in the analysis.
RESULTS
Out of 25 studies registered in clinical trial databases regarding melanoma screening, 20% research advanced imagining techniques employing innovative machine learning algorithms, while 16% explore behavioural interventions.
CONCLUSIONS
Intensification of behavioural interventions and health promotion activities is recommended.
背景
世界卫生组织报告称，2022年全球黑色素瘤发病率为331,722例，在最常见恶性肿瘤名单中排名第17位。这种疾病对公众健康构成威胁，因为黑色素瘤死亡导致的潜在寿命损失年数构成了经济和社会负担；然而，如果早期发现，它是可以治愈的。本研究旨在展示黑色素瘤筛查临床试验的当前趋势。
材料与方法
使用来自clinicaltrials.gov的数据进行分析。该分析考虑了黑色素瘤筛查的干预性和观察性研究。分析仅纳入了截至2024年9月4日具有完整和有效状态的研究。
结果
在临床试验数据库中注册的25项关于黑色素瘤筛查的研究中，20%的研究采用创新机器学习算法推进成像技术，而16%的研究探索行为干预措施。
结论
建议加强行为干预和健康促进活动。
Zotero 插件